Virtual meeting of the VSV-EBOPLUS project

Due to the COVID-19 crisis, the VSV-EBOPLUS Project meeting 2020 was held as online meeting on 21st and 22nd September 2020. Representatives of each Institution have attended the meeting, presenting and discussing the results and progresses. Two keynote speech were done during the two days of the meeting by Dr. Tom Monath (Crozet BioPharma LLC, USA) and by Dr. Galit Alter (Ragon Institute of MGH, MIT, and Harvard, USA) titled “Current status of and challenges for development of a recombinant VSV Nipah vaccine” and “Seroresponses to Ebola vaccines” respectively.